GB0906115D0 - Antibody and uses thereof - Google Patents

Antibody and uses thereof

Info

Publication number
GB0906115D0
GB0906115D0 GBGB0906115.1A GB0906115A GB0906115D0 GB 0906115 D0 GB0906115 D0 GB 0906115D0 GB 0906115 A GB0906115 A GB 0906115A GB 0906115 D0 GB0906115 D0 GB 0906115D0
Authority
GB
United Kingdom
Prior art keywords
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0906115.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fusion Antibodies Ltd
Original Assignee
Fusion Antibodies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fusion Antibodies Ltd filed Critical Fusion Antibodies Ltd
Priority to GBGB0906115.1A priority Critical patent/GB0906115D0/en
Publication of GB0906115D0 publication Critical patent/GB0906115D0/en
Priority to PCT/GB2010/000717 priority patent/WO2010116146A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB0906115.1A 2009-04-08 2009-04-08 Antibody and uses thereof Ceased GB0906115D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0906115.1A GB0906115D0 (en) 2009-04-08 2009-04-08 Antibody and uses thereof
PCT/GB2010/000717 WO2010116146A1 (en) 2009-04-08 2010-04-08 Anti-ecscr antibody and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0906115.1A GB0906115D0 (en) 2009-04-08 2009-04-08 Antibody and uses thereof

Publications (1)

Publication Number Publication Date
GB0906115D0 true GB0906115D0 (en) 2009-05-20

Family

ID=40750333

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0906115.1A Ceased GB0906115D0 (en) 2009-04-08 2009-04-08 Antibody and uses thereof

Country Status (2)

Country Link
GB (1) GB0906115D0 (en)
WO (1) WO2010116146A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103389376B (en) * 2013-08-21 2015-08-19 中南大学湘雅医院 Kit for evaluating clinical stage and prognosis of hepatocellular carcinoma and application of ECSCR

Also Published As

Publication number Publication date
WO2010116146A1 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
EP2494062A4 (en) Anti-glp-1r antibodies and their uses
ZA201107486B (en) Anti-tnf-x antibodies and their uses
IL250624A0 (en) Anti-fgfr3 antibodies and methods using same
IL209309A0 (en) Anti-fn14 antibodies and uses thereof
IL215291A0 (en) NOVEL ANTI-a5BETA1 ANTIBODIES AND USES THEREOF
IL216731A (en) P95-her2 antibodies and uses thereof
PT3091034T (en) Anti-cd40 antibodies and uses thereof
PT2406286T (en) Anti-cd40 antibodies and uses thereof
SMT202100676T1 (en) Anti-cd277 antibodies and uses thereof
EP2478110A4 (en) Class i anti-cea antibodies and uses thereof
SG10201401331TA (en) Anti-siglec-15 antibody
ZA201108310B (en) Blocking anti-dkk-1 antibodies and their uses
EP2411050A4 (en) Antibody constant domain regions and uses thereof
IL220536A0 (en) Anti - bv8 antibodies and uses thereof
IL214527A0 (en) Anti-mst1r antibodies and uses thereof
IL219136A0 (en) Anti-hepsin antibodies and methods using same
GB0903151D0 (en) Antibody uses and methods
EP2510000A4 (en) Anti-inflammatory antibodies and uses therefor
GB2473934B (en) Anti-VEEV antibody
GB0812277D0 (en) Antibody and uses thereof
GB0906115D0 (en) Antibody and uses thereof
GB0911712D0 (en) Antibody

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)